Postoperative aprotinin: Effect on blood loss and transfusion requirements in cardiac operations

Annals of Thoracic Surgery

Volumn 61, Issue 5, 1996, Pages 1372-1376

  Çiçek, Sertaç ^a,b   Demirkiliç, Ufuk ^a   Kuralay, Erkan ^a   Özal, Ertugrul ^a   Tatar, Harun ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0343618366     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00058-6     Document Type: Article

References (25)

1. Royston D, Taylor KM, Bidstrup BP, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 1987;2:1289-91.
2. Bidstrup BP, Royston D, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72.
3. Alajmo F, Calamai G, Perna AM, et al. High dose aprotinin: hemostatic effects in open-heart operations. Ann Thorac Surg 1989;48:536-9.
4. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaardhansen P. Effect of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:958-67.
5. Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-61.
6. Kawasuji M, Ueyama K, Sakakibara N, et al. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. Ann Thorac Surg 1993;55:1205-9.
7. Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031-8.
8. Sundt T, Saffitz JE, Stahl DJ, Waring TH, Kouchoukos NT. Renal dysfunction and intravascular coagulation after use of aprotinin in thoracic aortic operations employing circulatory arrest. Ann Thorac Surg 1993;55:1418-24.
9. Westaby S, Forni A, Dunning J, et al. Aprotinin and bleeding in profoundly hypothermic perfusion. Eur J Cardiothorac Surg 1994;8:82-6.
10. Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994;58:1580-8.
11. Arom KV, Emery RW. Decreased postoperative drainage with addition of ∈-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg 1994;57:1108-13.
12. Bick RL. Hemostasis defects associated with cardiac surgery, prosthetic devices and extracorporeal circuits. Semin Thromb Hemost 1989;15:173-7.
13. Tatar H, Cicek S, Demirkilic U, et al. Topical use of aprotinin in open heart operations. Ann Thorac Surg 1993;55:659-61.
14. Angelini GD, Cooper GJ, Lamarra M, Bryan AJ. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass. Lancet 1990;355:799-800.
15. Kallis P, Tooze JA, Talbot S, Cowans D, Bewan HD, Treasure T. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial. Eur J Cardiothorac Surg 1994;8:315-23.
16. Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Hansen PL. Comparison of effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108: 1083-91.
17. Köstering H, Kirchhof PG, Völker P, Warmann E, Koncz J. Untersuchungen der Blutgerinnungsveranderungen wahrend und nach Operation mit Hilfe der Herz-Lungen-Maschine. Thoraxchirurgie 1973;21:534-43.
18. Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990;63:241-5.
19. Lucas FV, Miller ML. The fibrinolytic system. Cleve Clin J Med 1988;55:531-41.
20. Michelson AD, Barnard MR. Plasmin-induced redistribution of platelet glycoprotein Ib. Blood 1990;76:2005-10.
21. Dahlback B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1994;77: 1-43.
22. Espana F, Estelles A, Griffin JH, Aznar J, Gilabert J. Aprotinin (Trasylol) is a competitive inhibitor of activated protein C. Thromb Res 1989;56:751-6.
23. Boldt J, Zickman B, Schindler E, Welters A, Dapper F, Hempelmann G. Influence of aprotinin on the thrombomodulin/protein C C system in pediatric cardiac operations. J Thorac Cardiovasc Surg 1994;107:1215-21.
24. Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 1983;33:479-94.
25. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.